- Home
- ENX vs MXCT Comparison
ENX vs MXCT Comparison
Compare ENX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- MXCT
- Stock Information
- Founded
- ENX 2002
- MXCT 1999
- Country
- ENX United States
- MXCT United States
- Employees
- ENX N/A
- MXCT N/A
- Industry
- ENX Finance/Investors Services
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ENX Finance
- MXCT Health Care
- Exchange
- ENX Nasdaq
- MXCT Nasdaq
- Market Cap
- ENX 169.0M
- MXCT 159.9M
- IPO Year
- ENX N/A
- MXCT 2021
- Fundamental
- Price
- ENX $10.00
- MXCT $1.55
- Analyst Decision
- ENX
- MXCT Buy
- Analyst Count
- ENX 0
- MXCT 4
- Target Price
- ENX N/A
- MXCT $7.50
- AVG Volume (30 Days)
- ENX 25.4K
- MXCT 577.9K
- Earning Date
- ENX 01-01-0001
- MXCT 11-05-2025
- Dividend Yield
- ENX 3.94%
- MXCT N/A
- EPS Growth
- ENX N/A
- MXCT N/A
- EPS
- ENX 0.16
- MXCT N/A
- Revenue
- ENX N/A
- MXCT $35,754,000.00
- Revenue This Year
- ENX N/A
- MXCT N/A
- Revenue Next Year
- ENX N/A
- MXCT $14.72
- P/E Ratio
- ENX $61.00
- MXCT N/A
- Revenue Growth
- ENX N/A
- MXCT N/A
- 52 Week Low
- ENX $7.84
- MXCT $1.26
- 52 Week High
- ENX $10.07
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- ENX 67.72
- MXCT 45.75
- Support Level
- ENX $9.91
- MXCT $1.60
- Resistance Level
- ENX $10.02
- MXCT $1.86
- Average True Range (ATR)
- ENX 0.05
- MXCT 0.11
- MACD
- ENX -0.01
- MXCT -0.02
- Stochastic Oscillator
- ENX 59.37
- MXCT 10.14
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.